-
1
-
-
0036829092
-
AGA technical review on nonalcoholic fatty liver disease
-
Sanyal AJ. AGA technical review on non-alcoholic fatty liver disease. Gastroenterology 2002;123:1705-25. (Pubitemid 35231670)
-
(2002)
Gastroenterology
, vol.123
, Issue.5
, pp. 1705-1725
-
-
Sanyal, A.J.1
-
2
-
-
84861901590
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012;107:811-26.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 811-826
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
-
5
-
-
3342958806
-
Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis
-
DOI 10.2337/diacare.27.8.2057
-
Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of non-alcoholic steatohepatitis. Diabetes Care 2004;27:2057-66. (Pubitemid 38989257)
-
(2004)
Diabetes Care
, vol.27
, Issue.8
, pp. 2057-2066
-
-
Medina, J.1
Fernandez-Salazar, L.I.2
Garcia-Buey, L.3
Moreno-Otero, R.4
-
6
-
-
74549140993
-
Prevalence and trends in obesity among US adults, 1999-2008
-
Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
-
(2010)
JAMA
, vol.303
, pp. 235-241
-
-
Flegal, K.M.1
Carroll, M.D.2
Ogden, C.L.3
Curtin, L.R.4
-
7
-
-
79959478969
-
Clinical practice. Chronic hepatitis C infection
-
Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011;364:2429-38.
-
(2011)
N Engl J Med
, vol.364
, pp. 2429-2438
-
-
Rosen, H.R.1
-
8
-
-
79960029926
-
Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
-
Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34:274-85.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 274-285
-
-
Vernon, G.1
Baranova, A.2
Younossi, Z.M.3
-
9
-
-
78650486196
-
Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
-
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M et al. Prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31.
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
Torres, D.M.4
Shaw, J.5
Contreras, M.6
-
10
-
-
70349770695
-
Epidemiology and natural history of non-alcoholic steatohepatitis
-
Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009;13:511-31.
-
(2009)
Clin Liver Dis
, vol.13
, pp. 511-531
-
-
Argo, C.K.1
Caldwell, S.H.2
-
11
-
-
80053581540
-
Frequency and outcomes of liver transplantation for non-alcoholic steatohepatitis in the United States
-
Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for non-alcoholic steatohepatitis in the United States. Gastroenterology 2011;141:1249-53.
-
(2011)
Gastroenterology
, vol.141
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
12
-
-
77952730428
-
The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
-
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology 2010;51:1972-8.
-
(2010)
Hepatology
, vol.51
, pp. 1972-1978
-
-
Ascha, M.S.1
Hanouneh, I.A.2
Lopez, R.3
Tamimi, T.A.4
Feldstein, A.F.5
Zein, N.N.6
-
13
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
DOI 10.1053/j.gastro.2005.04.014, PII S0016508505006943
-
Adams LA, Lymp JF, St SJ, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113-21. (Pubitemid 41002048)
-
(2005)
Gastroenterology
, vol.129
, Issue.1
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St, S.J.3
Sanderson, S.O.4
Lindor, K.D.5
Feldstein, A.6
Angulo, P.7
-
14
-
-
50649094716
-
Suspected non-alcoholic fatty liver disease and mortality risk in a population-based cohort study
-
Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM et al. Suspected non-alcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103:2263-71.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 2263-2271
-
-
Dunn, W.1
Xu, R.2
Wingard, D.L.3
Rogers, C.4
Angulo, P.5
Younossi, Z.M.6
-
15
-
-
79959573040
-
Endpoints and clinical trial design for non-alcoholic steatohepatitis
-
Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE et al. Endpoints and clinical trial design for non-alcoholic steatohepatitis. Hepatology 2011;54:344-53.
-
(2011)
Hepatology
, vol.54
, pp. 344-353
-
-
Sanyal, A.J.1
Brunt, E.M.2
Kleiner, D.E.3
Kowdley, K.V.4
Chalasani, N.5
Lavine, J.E.6
-
16
-
-
0032695030
-
Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis
-
Angulo P, Reach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999;30:1356-62.
-
(1999)
Hepatology
, vol.30
, pp. 1356-1362
-
-
Angulo, P.1
Reach, J.C.2
Batts, K.P.3
Lindor, K.D.4
-
17
-
-
33747503550
-
Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase
-
DOI 10.1097/00004836-200608000-00015, PII 0000483620060800000015
-
Pantsari MW, Harrison SA. Non-alcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase. J Clin Gastroenterol 2006;40:633-635. (Pubitemid 44259772)
-
(2006)
Journal of Clinical Gastroenterology
, vol.40
, Issue.7
, pp. 633-635
-
-
Pantsari, M.W.1
Harrison, S.A.2
-
18
-
-
84888298670
-
Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial
-
Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA et al. Longitudinal comparison between MRI, MRS and histology-determined steatosis in NAFLD patients at two-time points in a randomized trial. Hepatology 2013;58:1930-40.
-
(2013)
Hepatology
, vol.58
, pp. 1930-1940
-
-
Noureddin, M.1
Lam, J.2
Peterson, M.R.3
Middleton, M.4
Hamilton, G.5
Le, T.A.6
-
19
-
-
85027925485
-
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD
-
Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 2012;36:22-9.
-
(2012)
Aliment Pharmacol Ther
, vol.36
, pp. 22-29
-
-
Permutt, Z.1
Le, T.A.2
Peterson, M.R.3
Seki, E.4
Brenner, D.A.5
Sirlin, C.6
-
20
-
-
84865569519
-
Effect of colesevelam on liver fat quantified by magnetic resonance in non-alcoholic steatohepatitis: A randomized controlled trial
-
Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H et al. Effect of colesevelam on liver fat quantified by magnetic resonance in non-alcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012;56:922-32.
-
(2012)
Hepatology
, vol.56
, pp. 922-932
-
-
Le, T.A.1
Chen, J.2
Changchien, C.3
Peterson, M.R.4
Kono, Y.5
Patton, H.6
-
21
-
-
84863679715
-
What should we recommend to our patients with NAFLD regarding alcohol use?
-
Liangpunsakul S, Chalasani N. What should we recommend to our patients with NAFLD regarding alcohol use? Am J Gastroenterol 2012;107:976-8.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 976-978
-
-
Liangpunsakul, S.1
Chalasani, N.2
-
22
-
-
77649337140
-
Non-alcoholic fatty liver disease: Pathology and pathogenesis
-
Tiniakos DG, Vos MB, Brunt EM. Non-alcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010;5:145-71.
-
(2010)
Annu Rev Pathol
, vol.5
, pp. 145-171
-
-
Tiniakos, D.G.1
Vos, M.B.2
Brunt, E.M.3
-
23
-
-
79251535913
-
Non-invasive diagnosis of non-alcoholic fatty liver and non-alcoholic steatohepatitis
-
Adams LA, Feldstein AE. Non-invasive diagnosis of non-alcoholic fatty liver and non-alcoholic steatohepatitis. J Dig Dis 2011;12:10-6.
-
(2011)
J Dig Dis
, vol.12
, pp. 10-16
-
-
Adams, L.A.1
Feldstein, A.E.2
-
24
-
-
80555136061
-
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
-
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-49.
-
(2011)
Ann Med
, vol.43
, pp. 617-649
-
-
Musso, G.1
Gambino, R.2
Cassader, M.3
Pagano, G.4
-
25
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
DOI 10.1053/jhep.2003.50161
-
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Martini R et al. Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. (Pubitemid 36397405)
-
(2003)
Hepatology
, vol.37
, Issue.4
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
Natale, S.7
Vanni, E.8
Villanova, N.9
Melchionda, N.10
Rizzetto, M.11
-
26
-
-
33749186908
-
Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD
-
DOI 10.1111/j.1572-0241.2006.00719.x
-
Kang H, Greenson JK, Omo JT, Chao C, Peterman D, Anderson L et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 2006;101:2247-53. (Pubitemid 44477551)
-
(2006)
American Journal of Gastroenterology
, vol.101
, Issue.10
, pp. 2247-2253
-
-
Kang, H.1
Greenson, J.K.2
Omo, J.T.3
Chao, C.4
Peterman, D.5
Anderson, L.6
Foess-Wood, L.7
Sherbondy, M.A.8
Conjeevaram, H.S.9
-
28
-
-
84865545850
-
Association between diabetes, family history of diabetes, and risk of non-alcoholic steatohepatitis and fibrosis
-
Loomba R, Abraham M, Unalp A, Wilson L, Lavine J, Doo E et al. Association between diabetes, family history of diabetes, and risk of non-alcoholic steatohepatitis and fibrosis. Hepatology 2012;56:943-51.
-
(2012)
Hepatology
, vol.56
, pp. 943-951
-
-
Loomba, R.1
Abraham, M.2
Unalp, A.3
Wilson, L.4
Lavine, J.5
Doo, E.6
-
29
-
-
84887025674
-
Clinical and histological determinants of non-alcoholic steatohepatitis and advanced fibrosis in elderly patients
-
Epub ahead of print
-
Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A et al. Clinical and histological determinants of non-alcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 2013 [Epub ahead of print].
-
(2013)
Hepatology
-
-
Noureddin, M.1
Yates, K.P.2
Vaughn, I.A.3
Neuschwander-Tetri, B.A.4
Sanyal, A.J.5
McCullough, A.6
-
30
-
-
79251524594
-
Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
-
Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525-40.
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 525-540
-
-
Dowman, J.K.1
Tomlinson, J.W.2
Newsome, P.N.3
-
31
-
-
84155188801
-
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with non-alcoholic fatty liver disease
-
Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N et al. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with non-alcoholic fatty liver disease. Hepatology 2012;55:77-85.
-
(2012)
Hepatology
, vol.55
, pp. 77-85
-
-
Kowdley, K.V.1
Belt, P.2
Wilson, L.A.3
Yeh, M.M.4
Neuschwander-Tetri, B.A.5
Chalasani, N.6
-
32
-
-
84861981022
-
Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography
-
de LV, Vergniol J, Foucher J, Merrouche W, Le BB. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 2012;32:911-8.
-
(2012)
Liver Int
, vol.32
, pp. 911-918
-
-
De, L.V.1
Vergniol, J.2
Foucher, J.3
Merrouche, W.4
Le, B.B.5
-
33
-
-
84861961483
-
Controlled Attenuation Parameter (CAP): A noninvasive method for the detection of hepatic steatosis based on transient elastography
-
Myers RP, Pollett A, Kirsch R, Pomier-Layrargues G, Beaton M, Levstik M et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 2012;32:902-10.
-
(2012)
Liver Int
, vol.32
, pp. 902-910
-
-
Myers, R.P.1
Pollett, A.2
Kirsch, R.3
Pomier-Layrargues, G.4
Beaton, M.5
Levstik, M.6
-
34
-
-
84870819164
-
Liver stiffness measurement using XL probe in patients with non-alcoholic fatty liver disease
-
Wong VW, Vergniol J, Wong GL, Foucher J, Chan AW, Chermak F et al. Liver stiffness measurement using XL probe in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 2012;107:1862-71.
-
(2012)
Am J Gastroenterol
, vol.107
, pp. 1862-1871
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
Foucher, J.4
Chan, A.W.5
Chermak, F.6
-
35
-
-
84155188892
-
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
-
Myers RP, Pomier-Layrargues G, Kirsch R, Pollett A, Duarte-Rojo A, Wong D et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012;55:199-208.
-
(2012)
Hepatology
, vol.55
, pp. 199-208
-
-
Myers, R.P.1
Pomier-Layrargues, G.2
Kirsch, R.3
Pollett, A.4
Duarte-Rojo, A.5
Wong, D.6
-
36
-
-
77952529040
-
A position statement on NAFID/NASH based on the EASL 2009 special conference
-
Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFID/NASH based on the EASL 2009 special conference. J Hepatol 2010;53:372-84.
-
(2010)
J Hepatol
, vol.53
, pp. 372-384
-
-
Ratziu, V.1
Bellentani, S.2
Cortez-Pinto, H.3
Day, C.4
Marchesini, G.5
-
37
-
-
34247200322
-
Non-alcoholic fatty liver disease in the Asia-Pacific region: Definitions and overview of proposed guidelines
-
DOI 10.1111/j.1440-1746.2007.05001.x
-
Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007;22:778-87. (Pubitemid 46915352)
-
(2007)
Journal of Gastroenterology and Hepatology
, vol.22
, Issue.6
, pp. 778-787
-
-
Chitturi, S.1
Farrell, G.C.2
Hashimoto, E.3
Saibara, T.4
Lau, G.K.K.5
Sollano, J.D.6
-
38
-
-
0037406161
-
Prevalence and characteristics of pain induced by percutaneous liver biopsy
-
Eisenberg E, Konopniki M, Veitsman E, Kramskay R, Gaitini D, Baruch Y. Prevalence and characteristics of pain induced by percutaneous liver biopsy. Anesth Analg 2003;96:1392-6, table. (Pubitemid 36512882)
-
(2003)
Anesthesia and Analgesia
, vol.96
, Issue.5
, pp. 1392-1396
-
-
Eisenberg, E.1
Konopniki, M.2
Veitsman, E.3
Kramskay, R.4
Gaitini, D.5
Baruch, Y.6
-
39
-
-
34247525006
-
The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies
-
Huang JF, Hsieh MY, Dai CY, Hou NJ, Lee LP, Lin ZY et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut 2007;56:736-7.
-
(2007)
Gut
, vol.56
, pp. 736-737
-
-
Huang, J.F.1
Hsieh, M.Y.2
Dai, C.Y.3
Hou, N.J.4
Lee, L.P.5
Lin, Z.Y.6
-
40
-
-
0028913123
-
Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: An audit by the British Society of Gastroenterology and the Royal College of Physicians of London
-
Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-41.
-
(1995)
Gut
, vol.36
, pp. 437-441
-
-
Gilmore, I.T.1
Burroughs, A.2
Murray-Lyon, I.M.3
Williams, R.4
Jenkins, D.5
Hopkins, A.6
-
41
-
-
0022647490
-
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
-
Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-73. (Pubitemid 16125908)
-
(1986)
Journal of Hepatology
, vol.2
, Issue.2
, pp. 165-173
-
-
Piccinino, F.1
Sagnelli, E.2
Pasquale, G.3
-
42
-
-
0017927812
-
Liver biopsy: Complications in 1000 inpatients and outpatients
-
Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978;74:103-6. (Pubitemid 8248893)
-
(1978)
Gastroenterology
, vol.74
, Issue.1
, pp. 103-106
-
-
Perrault, J.1
McGill, D.B.2
Ott, B.J.3
Taylor, W.F.4
-
43
-
-
0025119535
-
A 21-year experience with major hemorrhage after percutaneous liver biopsy
-
McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400. (Pubitemid 20381876)
-
(1990)
Gastroenterology
, vol.99
, Issue.5
, pp. 1396-1400
-
-
McGill, D.B.1
Rakela, J.2
Zinsmeister, A.R.3
Ott, B.J.4
-
44
-
-
63349097089
-
Liver biopsy
-
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009;49:1017-44.
-
(2009)
Hepatology
, vol.49
, pp. 1017-1044
-
-
Rockey, D.C.1
Caldwell, S.H.2
Goodman, Z.D.3
Nelson, R.C.4
Smith, A.D.5
-
45
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
-
DOI 10.1053/j.gastro.2005.03.084, PII S001650850500630X
-
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E et al. Sampling variability of liver biopsy in non-alcoholic fatty liver disease. Gastroenterology 2005;128:1898-906. (Pubitemid 40824701)
-
(2005)
Gastroenterology
, vol.128
, Issue.7
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
Gombert, S.4
Giral, P.5
Bruckert, E.6
Grimaldi, A.7
Capron, F.8
Poynard, T.9
-
46
-
-
78649433367
-
Histopathology of non-alcoholic fatty liver disease
-
Brunt EM, Tiniakos DG. Histopathology of non-alcoholic fatty liver disease. World J Gastroenterol 2010;16:5286-96.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 5286-5296
-
-
Brunt, E.M.1
Tiniakos, D.G.2
-
47
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
DOI 10.1002/hep.20701
-
Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005;41:1313-21. (Pubitemid 40770284)
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.-C.8
Torbenson, M.S.9
Unalp-Arida, A.10
Yeh, M.11
McCullough, A.J.12
Sanyal, A.J.13
|